Get startedLog in
    Picture of BioSino Bio-technology and Science logo

    8247 — BioSino Bio-technology and Science Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for BioSino Bio-technology and Science, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue348373289263184
    Cost of Revenue
    Gross Profit14414612710870.9
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses333354313313245
    Operating Profit15.418.8-23.6-50-60.5
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes6.4118.5-17.6-59.7-67.2
    Provision for Income Taxes
    Net Income After Taxes3.1614.2-19.2-56.9-65
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-1.148.11-11.6-42.5-51.1
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-1.148.11-11.6-42.5-51.1
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.0050.06-0.078-0.219-0.326